Search Ontology:
ChEBI

icatibant

Term ID
CHEBI:68556
Synonyms
  • (2S)-2-({[(2S,3aS,7aS)-1-({(3R)-2-[(2S)-2-{[(2S)-2-[2-({[(2S,4R)-1-({(2S)-1-[(2S)-2-{[(2R)-2-amino-5-carbamimidamidopentanoyl]amino}-5-carbamimidamidopentanoyl]pyrrolidin-2-yl}carbonyl)-4-hydroxypyrrolidin-2-yl]carbonyl}amino)acetamido]-3-(thiophen-2-yl)p
  • D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2alpha,3abeta,7abeta)-octahydro-1H-indole-2-carbonyl-L-arginine
  • H-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH
  • icatibant
  • icatibanto
  • icatibantum
Definition
A ten-membered synthetic oligopeptide consisting of D-Arg, Arg, Pro, Hyp, Gly, Thi, Ser, D-Tic, Oic, and Arg residues joined in sequrence. A bradykinin receptor antagonist used as its acetate salt for the treatment of acute attacks of hereditary angioedema in adult patients.
References
  • cas:130308-48-4
  • drugbank:DB06196
  • pubmed:21959973
  • pubmed:22142018
  • pubmed:22386830
  • pubmed:22434085
  • pubmed:22435954
  • pubmed:22507340
  • pubmed:22519593
  • pubmed:22522852
  • pubmed:22552531
  • pubmed:22577166
  • pubmed:22577920
  • pubmed:22584193
  • pubmed:22686628
  • pubmed:22691903
  • pubmed:22797560
  • pubmed:22830287
  • pubmed:22904641
  • pubmed:22936825
  • pubmed:22958093
  • pubmed:22970904
  • reaxys:8185933
  • wikipedia.en:Icatibant
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from icatibant
Phenotype where environments contain icatibant
Phenotype modified by environments containing icatibant
Phenotype affecting icatibant
Human Disease Model